Search

April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.

Directors and Officers/Management Liability Insurance
Protect your directors and officers from liabilities related to the operation and management of a business. It provides assurance in the event they are sued in conjunction with the performance of their duties as they relate to the healthcare organization—allowing them to make important business decisions without fear of personal financial loss.

Detecting and Addressing Incidental Findings: Medical Malpractice Claims
With the use of current imaging technology, it has become more common to find abnormalities, or “incidental findings,” that are unrelated to the reason the imaging was ordered. This review of closed claims from The Doctors Company examines factors that contribute to missed incidental findings and offers strategies to improve follow-up and prevent patient harm.

Video Nov 15, 2023
Shoulder Dystocia: Physician-Patient Disclosure
The purpose of this video is to assist physicians in enhancing their communication skills when disclosing a shoulder dystocia injury to patients and family members. This type of injury to the infant may unfortunately occur, despite the best of care. However, effective physician-patient communication is an integral part of clinical practice and has shown to positively influence outcomes by increasing patient understanding and trust.

Mike Tungate
Mike Tungate is president of The Doctors Agency of Michigan.

The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to the pending acquisition of ProAssurance by The Doctors Company.

Stay in the Know

Sign Up for The Doctor’s Practice

Our monthly e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe